Our results from quantitative RT-PCR, Western blotting, and the TMA immunostaining of 45 patient specimens, including both normal thyroid and MTC samples, confirmed that the VGSC subtype NaV1.7 was specifically overexpressed in MTC, while it was not expressed in normal thyroid cells and tissues. Here, SCN9A is linked to medullary thyroid gland carcinoma.